MELBOURNE, Australia, Oct. 22, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the spin-off of Rhine Pharma[1], which has the mission of expanding global access to innovative radiopharmaceuticals for cancer imaging and treatment using two...
Telix Spins Off Rhine Pharma™ to Expand Global Access to Radiopharmaceuticals
Seaking AlphaSeeking Alpha / Seaking Alpha 15 hours ago 1 Views
Comments